Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3652498011 | Product containing galactose and palmitic acid (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3714979017 | Galactose- and palmitic acid-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galactose- and palmitic acid-containing product | Is a | Galactose-containing product | true | Inferred relationship | Some | ||
| Galactose- and palmitic acid-containing product | Has active ingredient | Galactose | true | Inferred relationship | Some | 1 | |
| Galactose- and palmitic acid-containing product | Has active ingredient | Palmitic acid | true | Inferred relationship | Some | 2 | |
| Galactose- and palmitic acid-containing product | Is a | Carboxylic acid and/or carboxylic acid derivative-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Galactose- and palmitic acid-containing product in parenteral dose form | Is a | True | Galactose- and palmitic acid-containing product | Inferred relationship | Some | |
| Galactose and palmitic acid only product | Is a | True | Galactose- and palmitic acid-containing product | Inferred relationship | Some | |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial | Is a | False | Galactose- and palmitic acid-containing product | Inferred relationship | Some | |
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial | Is a | False | Galactose- and palmitic acid-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR